Dx to Rx – Transitioning from Diagnostics to Pharma
In this episode, Namratha Sastry shares her journey into the Medical Science Liaison (MSL) role, beginning with her first experience at Biodesics. She delves into the importance of networking in career transitions, particularly moving from diagnostics to pharma, and discusses the regulatory differences and training experiences across these sectors. Namratha compares interactions with commercial teams and Key Opinion Leaders (KOLs) in both fields, offering advice for transitioning between company sizes. She provides valuable tips for aspiring diagnostics MSLs, interview preparation, and the advantages of diverse experiences. The episode concludes with career insights and holiday wishes for MSLs in 2023.
My guest today is Namratha Sastry, PhD, Associate Director of Field Medical Affairs, Oncology at Regeneron and we discuss the transition from diagnostics and Pharma
"The views and opinions expressed in the following presentation are those of the individual presenter and should not be attributed to any organization with which the presenter is employed or affiliated."
Namratha shares….
👉 The differences and similarities between Dx MSLs and Rx MSLs differences in terms of regulation between the two types of companies
👉 How KOL interactions are handled in a Dx role vs Pharma
👉 What the relationship is like with commercial in a diagnostics MSL role
👉 What the relationship is like with commercial in a diagnostics MSL role
